BIOS Fund I, LP

10% owner at LTRN

Sold, on record
$2M
Dollars the filings state
Form 4 sales
3
Latest Jun 12, 2025
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • LTRNLantern Pharma Inc.10% owner

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale LTRNUnusual
    Nov 8, 2022 2022

    Sold 350,000 shares at $4.40 ($1.5M)

    BIOS Fund I, LP, 10% owner

    Sold 68.1% of holdings ($2.3M position)164,137 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale LTRNUnusual
    Jan 17, 2024 +435 days

    Sold 58,889 shares at $4.20 ($247k)

    BIOS Fund I, LP, 10% owner

    No 10b5-1 planSold 25.9% of holdings ($955k position)168,417 shares leftFiling

  3. 3 Form 144 notice LTRNNotice
    Apr 26, 2024 +100 days

    Filed to sell 371,950 shares ($2M)

    BIOS Fund I, LP, Affiliate (10% owner)

    No 10b5-1 planFiling

  4. 4 Form 4 sale LTRNUnusual
    Jun 12, 2025 +412 days

    Sold 61,613 shares at $3.38 ($208k)

    BIOS Fund I, LP, 10% owner

    No 10b5-1 planSold 34.2% of holdings ($609k position)118,626 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by BIOS Fund I, LP
Source
Jun 12, 2025Jun 13, 2025LTRN10% ownerForm 4 sale61,613$208k34.2%UnusualSEC
Apr 26, 2024Apr 26, 2024LTRNAffiliate (10% owner)Form 144 notice371,950$2MNoticeSEC
Jan 17, 2024Jan 19, 2024LTRN10% ownerForm 4 sale58,889$247k25.9%UnusualSEC
Nov 8, 2022Nov 9, 2022LTRN10% ownerForm 4 sale350,000$1.5M68.1%UnusualSEC